563 related articles for article (PubMed ID: 25667973)
21. Prevalence of human papillomavirus types in high-grade cervical intraepithelial neoplasia and cancer in Italy.
Carozzi FM; Tornesello ML; Burroni E; Loquercio G; Carillo G; Angeloni C; Scalisi A; Macis R; Chini F; Buonaguro FM; Giorgi Rossi P;
Cancer Epidemiol Biomarkers Prev; 2010 Sep; 19(9):2389-400. PubMed ID: 20826836
[TBL] [Abstract][Full Text] [Related]
22. HPV genotype distribution according to severity of cervical neoplasia.
Sjoeborg KD; Tropé A; Lie AK; Jonassen CM; Steinbakk M; Hansen M; Jacobsen MB; Cuschieri K; Eskild A
Gynecol Oncol; 2010 Jul; 118(1):29-34. PubMed ID: 20406711
[TBL] [Abstract][Full Text] [Related]
23. Prevalence of Human Papillomavirus Genotypes Among Women With High-Grade Cervical Lesions in Beijing, China.
Xiao M; Xu Q; Li H; Gao H; Bie Y; Zhang Z
Medicine (Baltimore); 2016 Jan; 95(3):e2555. PubMed ID: 26817906
[TBL] [Abstract][Full Text] [Related]
24. HIGH-RISK HPV testing as the primary screening method in an organized regional screening program for cervical cancer: the value of HPV16 and HPV18 genotyping?
Kares S; Veijalainen O; Kholová I; Tirkkonen M; Vuento R; Huhtala H; Tuimala V; Mäenpää J; Kujala P
APMIS; 2019 Nov; 127(11):710-716. PubMed ID: 31403733
[TBL] [Abstract][Full Text] [Related]
25. Differences in human papillomavirus type distribution in high-grade cervical intraepithelial neoplasia and invasive cervical cancer in Europe.
Tjalma WA; Fiander A; Reich O; Powell N; Nowakowski AM; Kirschner B; Koiss R; O'Leary J; Joura EA; Rosenlund M; Colau B; Schledermann D; Kukk K; Damaskou V; Repanti M; Vladareanu R; Kolomiets L; Savicheva A; Shipitsyna E; Ordi J; Molijn A; Quint W; Raillard A; Rosillon D; De Souza SC; Jenkins D; Holl K;
Int J Cancer; 2013 Feb; 132(4):854-67. PubMed ID: 22752992
[TBL] [Abstract][Full Text] [Related]
26. Safety of extending screening intervals beyond five years in cervical screening programmes with testing for high risk human papillomavirus: 14 year follow-up of population based randomised cohort in the Netherlands.
Dijkstra MG; van Zummeren M; Rozendaal L; van Kemenade FJ; Helmerhorst TJ; Snijders PJ; Meijer CJ; Berkhof J
BMJ; 2016 Oct; 355():i4924. PubMed ID: 27702796
[TBL] [Abstract][Full Text] [Related]
27. [Risk stratification of type-specific human papillomavirus for cervical precancers: evidence from a cross-sectional study in Shenzhen].
Liu ZH; Lin W; Wang YY; Wu B; Yuan SX; Yao JL; Zhao XS; Chen B; Qiao YL; Zhao FH; Chen W; Hu SY
Zhonghua Zhong Liu Za Zhi; 2018 Oct; 40(10):757-763. PubMed ID: 30392340
[No Abstract] [Full Text] [Related]
28. Human papillomavirus (HPV) type distribution in cervical carcinoma, low-grade, and high-grade squamous intraepithelial lesions in Venezuelan women.
Correnti M; Medina F; Cavazza ME; Rennola A; Avila M; Fernándes A
Gynecol Oncol; 2011 Jun; 121(3):527-31. PubMed ID: 21421263
[TBL] [Abstract][Full Text] [Related]
29. Stratifying HPV-positive women for CIN3+ risk after one and two rounds of HPV-based screening.
Veldhuijzen NJ; Polman NJ; Snijders PJF; Meijer CJLM; Berkhof J
Int J Cancer; 2017 Oct; 141(8):1551-1560. PubMed ID: 28670823
[TBL] [Abstract][Full Text] [Related]
30. Type-specific HPV prevalence in invasive cervical cancer in the UK prior to national HPV immunisation programme: baseline for monitoring the effects of immunisation.
Mesher D; Cuschieri K; Hibbitts S; Jamison J; Sargent A; Pollock KG; Powell N; Wilson R; McCall F; Fiander A; Soldan K
J Clin Pathol; 2015 Feb; 68(2):135-40. PubMed ID: 25410654
[TBL] [Abstract][Full Text] [Related]
31. [Performance of combined liquid based cytology and HPV nucleic acid test for detecting cervical precancer among women attending screening].
Jiang MY; Feng RM; Wang L; Li TY; Zhang AA; Cui JF; Pan QJ; Zhang X; Liu ML; Gao F; Chen W; Qiao YL
Zhonghua Zhong Liu Za Zhi; 2018 Oct; 40(10):750-756. PubMed ID: 30392339
[No Abstract] [Full Text] [Related]
32. Methylation of HPV18, HPV31, and HPV45 genomes and cervical intraepithelial neoplasia grade 3.
Wentzensen N; Sun C; Ghosh A; Kinney W; Mirabello L; Wacholder S; Shaber R; LaMere B; Clarke M; Lorincz AT; Castle PE; Schiffman M; Burk RD
J Natl Cancer Inst; 2012 Nov; 104(22):1738-49. PubMed ID: 23093560
[TBL] [Abstract][Full Text] [Related]
33. HPV Testing With 16, 18, and 45 Genotyping Stratifies Cancer Risk for Women With Normal Cytology.
Stoler MH; Wright TC; Parvu V; Yanson K; Eckert K; Kodsi S; Cooper C
Am J Clin Pathol; 2019 Mar; 151(4):433-442. PubMed ID: 30649177
[TBL] [Abstract][Full Text] [Related]
34. Prevalence and genotyping of high risk human papillomavirus in cervical cancer samples from Punjab, Pakistan.
Siddiqa A; Zainab M; Qadri I; Bhatti MF; Parish JL
Viruses; 2014 Jul; 6(7):2762-77. PubMed ID: 25036463
[TBL] [Abstract][Full Text] [Related]
35. The effectiveness of HPV16 and HPV18 genotyping and cytology with different thresholds for the triage of human papillomavirus-based screening on self-collected samples.
Song F; Du H; Wang C; Huang X; Wu R;
PLoS One; 2020; 15(6):e0234518. PubMed ID: 32525936
[TBL] [Abstract][Full Text] [Related]
36. Human papillomavirus (HPV) genotypes in women with cervical precancer and cancer at Kaiser Permanente Northern California.
Castle PE; Shaber R; LaMere BJ; Kinney W; Fetterma B; Poitras N; Lorey T; Schiffman M; Dunne A; Ostolaza JM; McKinney S; Burk RD
Cancer Epidemiol Biomarkers Prev; 2011 May; 20(5):946-53. PubMed ID: 21415357
[TBL] [Abstract][Full Text] [Related]
37. Incidence risk of cervical intraepithelial neoplasia 3 or more severe lesions is a function of human papillomavirus genotypes and severity of cytological and histological abnormalities in adult Japanese women.
Hosaka M; Fujita H; Hanley SJ; Sasaki T; Shirakawa Y; Abiko M; Kudo M; Kaneuchi M; Watari H; Kikuchi K; Sakuragi N
Int J Cancer; 2013 Jan; 132(2):327-34. PubMed ID: 22729477
[TBL] [Abstract][Full Text] [Related]
38. Real-world data on cervical cancer risk stratification by cytology and HPV genotype to inform the management of HPV-positive women in routine cervical screening.
Hashim D; Engesæter B; Baadstrand Skare G; Castle PE; Bjørge T; Tropé A; Nygård M
Br J Cancer; 2020 May; 122(11):1715-1723. PubMed ID: 32242098
[TBL] [Abstract][Full Text] [Related]
39. High-risk HPV genotypes in Zimbabwean women with cervical cancer: Comparative analyses between HIV-negative and HIV-positive women.
Kuguyo O; Dube Mandishora RS; Thomford NE; Makunike-Mutasa R; Nhachi CFB; Matimba A; Dandara C
PLoS One; 2021; 16(9):e0257324. PubMed ID: 34582476
[TBL] [Abstract][Full Text] [Related]
40. HPV-genotypes in high-grade intraepithelial cervical lesions in Danish women.
Kirschner B; Schledermann D; Holl K; Rosenlund M; Raillard A; Quint W; Molijn A; Jenkins D; Junge J
Acta Obstet Gynecol Scand; 2013 Sep; 92(9):1032-40. PubMed ID: 23647074
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
